Harald Vogelsang

Intestinal permeability and the prediction of relapse in Crohn's disease

John P. Wyatt, Harald Vogelsang, Wolfgang Hübl et al. · The Lancet · 1993 · 627 citations

Inflammation, Intestinal Permeability, Mucosal Immunology +7

The value of serologic markers in indeterminate colitis: A prospective follow-up study

Sofie Joossens, Walter Reinisch, Séverine Vermeire et al. · Gastroenterology · 2002 · 328 citations · Full text

Inflammation, Indeterminate Colitis, Immunology +9

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou et al. · Gastroenterology · 2016 · 320 citations · Full text

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

Thomas Reiberger, Arnulf Ferlitsch, B.A. Payer et al. · Journal of Hepatology · 2012 · 318 citations

Inflammation, Intestinal Permeability, Non-selective Betablocker Therapy +11

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

Cornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich et al. · Gut · 2013 · 296 citations